| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.5.238/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.238 |
| Version | 20220112 |
| Status | active |
| Date | 2022-01-12T01:02:12-05:00 |
| Name | FirstLineDrugTherapyForMetastaticColorectalCancer |
| Title | First Line Drug Therapy for Metastatic Colorectal Cancer |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medications for first-line drug therapy for metastatic colorectal cancer.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for first-line drug therapy for metastatic colorectal cancer: leucovorin, panitumumab, bevacizumab, capecitabine, cetuximab, pembrolizumab, fluorouracil, oxaliplatin, irinotecan, ipilimumab, nivolumab.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
No resources found
| CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm  | RxNorm |
| http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169 | Irinotecan Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179 | Bevacizumab Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210 | Capecitabine Oral |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61 | Cetuximab Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.100 | Injectable Fluorouracil |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.132 | Oxaliplatin Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.187 | Ipilimumab Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.188 | Nivolumab Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.189 | Pembrolizumab Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1205 | Leucovorin |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.1444.5.238",
"meta" : {
"versionId" : "9",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "American Society of Clinical Oncology Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-07-31"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2022-01-12"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.238",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.1444.5.238"
}
],
"version" : "20220112",
"name" : "FirstLineDrugTherapyForMetastaticColorectalCancer",
"title" : "First Line Drug Therapy for Metastatic Colorectal Cancer",
"status" : "active",
"experimental" : false,
"date" : "2022-01-12T01:02:12-05:00",
"publisher" : "American Society of Clinical Oncology Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medications for first-line drug therapy for metastatic colorectal cancer.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for first-line drug therapy for metastatic colorectal cancer: leucovorin, panitumumab, bevacizumab, capecitabine, cetuximab, pembrolizumab, fluorouracil, oxaliplatin, irinotecan, ipilimumab, nivolumab.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
"compose" : {
"include" : [
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.188"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.187"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.100"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1205"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.132"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.63"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.189"
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:5609d29e-283e-47a0-9def-a674062eb1f4",
"timestamp" : "2024-12-10T10:13:49-05:00",
"total" : 48,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657005",
"display" : "40 ML ipilimumab 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657012",
"display" : "10 ML ipilimumab 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657066",
"display" : "4 ML bevacizumab 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657073",
"display" : "16 ML bevacizumab 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657190",
"display" : "4 ML nivolumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657195",
"display" : "10 ML nivolumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657658",
"display" : "50 ML cetuximab 2 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657663",
"display" : "100 ML cetuximab 2 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657703",
"display" : "5 ML panitumumab 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657722",
"display" : "20 ML panitumumab 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657746",
"display" : "pembrolizumab 50 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657750",
"display" : "4 ML pembrolizumab 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1719772",
"display" : "10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1726319",
"display" : "2 ML irinotecan hydrochloride 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1726324",
"display" : "5 ML irinotecan hydrochloride 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1726333",
"display" : "15 ML irinotecan hydrochloride 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1726492",
"display" : "25 ML irinotecan hydrochloride 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1736776",
"display" : "10 ML oxaliplatin 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1736781",
"display" : "20 ML oxaliplatin 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1736784",
"display" : "oxaliplatin 50 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1736786",
"display" : "oxaliplatin 100 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1791701",
"display" : "10 ML fluorouracil 50 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1791736",
"display" : "20 ML fluorouracil 50 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1797528",
"display" : "40 ML oxaliplatin 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1803930",
"display" : "leucovorin 50 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1803932",
"display" : "leucovorin 100 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1803937",
"display" : "leucovorin 200 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197860",
"display" : "leucovorin 10 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197861",
"display" : "leucovorin 15 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197862",
"display" : "leucovorin 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197863",
"display" : "leucovorin 5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1991412",
"display" : "24 ML nivolumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "200327",
"display" : "capecitabine 150 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "200328",
"display" : "capecitabine 500 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2046140",
"display" : "16 ML bevacizumab-awwb 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2046148",
"display" : "4 ML bevacizumab-awwb 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2055036",
"display" : "leucovorin 500 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2099993",
"display" : "10 ML leucovorin 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2104714",
"display" : "50 ML leucovorin 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2268039",
"display" : "4 ML bevacizumab-bvzr 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2268047",
"display" : "16 ML bevacizumab-bvzr 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "237788",
"display" : "leucovorin 350 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "239177",
"display" : "fluorouracil 50 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2569080",
"display" : "12 ML nivolumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2599043",
"display" : "4 ML bevacizumab-maly 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2599051",
"display" : "16 ML bevacizumab-maly 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2627650",
"display" : "4 ML bevacizumab-adcd 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2627658",
"display" : "16 ML bevacizumab-adcd 25 MG/ML Injection"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.